Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 989 | 952 | 888 | 1,043 | 1,078 |
| Income taxes - deferred | 26 | 9 | 9 | -162 | 181 |
| Accounts receivable | -491 | -130 | 556 | 1,826 | -503 |
| Other Working Capital | -2,099 | -1,771 | 1,489 | 2,037 | -1,153 |
| Other Operating Activity | -26 | 395 | 243 | -1,015 | 446 |
| Operating Cash Flow | $-1,602 | $-546 | $3,186 | $3,728 | $49 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -76 | -241 | -193 | 434 | -908 |
| Net Acquisitions | N/A | N/A | N/A | -887 | -8 |
| Sale Of Investment | 347 | 17 | 178 | 185 | 92 |
| Other Investing Activity | -78 | 0 | 0 | -96 | 0 |
| Investing Cash Flow | $193 | $-223 | $-14 | $-364 | $-824 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 99 | 434 |
| Dividend Paid | N/A | N/A | N/A | -126 | -977 |
| Other Financing Activity | -826 | -706 | -746 | -449 | -709 |
| Financing Cash Flow | $-826 | $-706 | $-746 | $-476 | $-1,251 |
| Exchange Rate Effect | N/A | N/A | 49 | N/A | N/A |
| Beginning Cash Position | 3,898 | 5,470 | 2,996 | -37 | 2,041 |
| End Cash Position | 1,777 | 3,898 | 5,470 | 3,030 | -37 |
| Net Cash Flow | $-2,235 | $-1,475 | $2,425 | $2,888 | $-2,026 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,602 | -546 | 3,186 | 3,728 | 49 |
| Capital Expenditure | -76 | -241 | -193 | N/A | -908 |
| Free Cash Flow | -1,678 | -787 | 2,993 | 3,728 | -859 |